Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

• Michele D. Spring ,

  * E-mail: michele.spring@us.army.mil

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• James F. Cummings,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Christian F. Ockenhouse,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Sheetij Dutta,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Randall Reidler,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Evelina Angov,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Elke Bergmann-Leitner,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• V. Ann Stewart,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Stacey Bittner,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Laure Juompan,

  Current address: Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Rockville, Maryland, United States of America,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Mark G. Kortepeter,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Robin Nielsen,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Urszula Krzych,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Ev Tierney,

  Affiliation Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative, Bethesda, Maryland, United States of America

  ⨯
• Lisa A. Ware,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Megan Dowler,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Cornelus C. Hermsen,

  Affiliation Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Robert W. Sauerwein,

  Affiliation Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Sake J. de Vlas,

  Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

  ⨯
• Opokua Ofori-Anyinam,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• David E. Lanar,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Jack L. Williams,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Kent E. Kester,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Kathryn Tucker,

  Affiliation Statistics Collaborative, Incorporated, Washington D. C., United States of America

  ⨯
• Meng Shi,

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Elissa Malkin,

  Affiliation Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative, Bethesda, Maryland, United States of America

  ⨯
• Carole Long,

  Affiliation Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Carter L. Diggs,

  Affiliation Malaria Vaccine Development Program, United States Agency for International Development, Washington D. C., United States of America

  ⨯
• Lorraine Soisson,

  Affiliation Malaria Vaccine Development Program, United States Agency for International Development, Washington D. C., United States of America

  ⨯
• Marie-Claude Dubois,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• W. Ripley Ballou,

  Current address: Bill and Melinda Gates Foundation, Seattle, Washington, United States of America

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• Joe Cohen,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
•  [ ... ],
• D. Gray Heppner Jr

  Affiliation United States Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]